quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:45:46·1137d
NEWSRelease
Amryt Pharma plc logo
Cardiovascular Systems Inc. logo
Immuneering Corporation logo
+2

Top 5 Health Care Stocks That Are Ticking Portfolio Bombs

AMYT· Amryt Pharma plcCSII· Cardiovascular Systems Inc.IMRX· Immuneering CorporationPRVB· Provention Bio Inc.PTGX· Protagonist Therapeutics Inc.
Health Care
Original source

Companies

  • AMYT
    Amryt Pharma plc
    Health Care
  • CSII
    Cardiovascular Systems Inc.
    Health Care
  • IMRX
    Immuneering Corporation
    Health Care
  • PRVB
    Provention Bio Inc.
    Health Care
  • PTGX
    Protagonist Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Oct 31IMRXUpdateLeerink Partners$15.00
  • Sep 17PTGXUpdateBarclays$72.00
  • Sep 12PTGXUpdateLeerink Partners$73.00
  • Jun 17PTGXUpdateCitigroup$72.00
  • Dec 13IMRXUpdateMorgan Stanley-
  • Dec 6PTGXUpdateGoldman$47.00

Related

  • FDA17h
    FDA Approval for TZIELD issued to PROVENTION BIO INC
  • INSIDER2d
    SEC Form 4 filed by Ali Asif
  • PR2d
    Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting
  • SEC3d
    SEC Form DEFA14A filed by Immuneering Corporation
  • SEC3d
    SEC Form DEF 14A filed by Immuneering Corporation
  • PR4d
    Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
  • NEWS7d
    Protagonist Therapeutics Reports Granting of Inducement Awards
  • PR17d
    Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022